ERA-EDTA 2011 Congress

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Similar Survival Rates for Hemodiafiltration and Hemodialysis

Daniel M. Keller, PhD July 26, 2011

PRAGUE—End-stage renal disease patients on post-dilution online hemodiafiltration (HDF) or high-flux hemodialysis (HD) have the same overall survival and non-fatal cardiovascular (CV) event rates, new findings show.

Survival Better with HD than PD in CHF Patients

Daniel M. Keller, PhD July 21, 2011

PRAGUE—For patients with congestive heart failure (CHF) who initiate maintenance dialysis, those starting on peritoneal dialysis (PD) have a significantly greater death risk than those starting on hemodialysis (HD), according to a French study.

PP Declines Predict Worse HD Patient Survival

Daniel M. Keller, PhD July 20, 2011

PRAGUE—Decreases in pulse pressure (PP), and to a lesser extent increases, predict worse survival in the first year for patients new to hemodialysis (HD), new findings suggest.

LDL Lowering Fails to Slow Renal Disease Progression

Daniel M. Keller, PhD July 19, 2011

PRAGUE—Lowering LDL cholesterol (LDL) can prevent or even reverse atherosclerosis, but it does not do the same for the progression of chronic kidney disease (CKD).

HDL from CDK Patients Loses Vasoprotective Effects

Daniel M. Keller, PhD July 18, 2011

PRAGUE—HDL cholesterol (HDL) in patients with chronic kidney disease (CKD) loses its protective effect on vascular endothelium, new findings suggest. Rather than supporting the beneficial functions of the endothelium, it appears to become pro-inflammatory and inhibit them.

NP-Based Program Helps Control CKD Cardiac Risk Factors

Daniel M. Keller, PhD July 18, 2011

PRAGUE—A multifactorial intervention using a polydrug and lifestyle treatment strategy with nurse practitioner (NP) support can improve management of some cardiovascular (CV) risk factors and reduced the number of physician visits by patients with chronic kidney disease (CKD).

Paricalcitol Superior for Lowering iPTH

Daniel M. Keller, PhD July 18, 2011

The drug was more likely than cinacalcet to achieve a 50 percent or greater decrease in iPTH from baseline.

Hyponatremia May Predict Contrast-Induced Nephropathy

Jody A. Charnow July 05, 2011

PRAGUE—Transient hyponatremia may precede development of contrast-induced nephropathy (CIN) in patients undergoing coronary angiography, according to investigators.

Study: PD Patients Receive Kidney Transplants Sooner

Jody A. Charnow June 28, 2011

PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.

Post-Transplantation Anemia Risk Factors Identified

Jody A. Charnow June 28, 2011

PRAGUE—Renal transplant recipients who have anemia three months after receiving a kidney are more likely to have anemia more than six months post-transplant, according to researchers.